Combination of proton-pump inhibitor and anti-CD3 F(ab')2 for islet neogenesis and immune modulation in type 1 diabetes
{{output}}
Introduction: Type 1 diabetes (T1D) is an autoimmune disease characterized by T cell-mediated destruction of pancreatic β cells. Current insulin therapy does not address autoimmune pathology or restore endogenous β-cell functio... ...
